Poolbeg Pharma plc - Agreement signed for MelioVac with University College Dublin
POLB
Mon, 06 Dec 2021, 07:05am GMT
Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model.
Industry: Health Care
Contact: +44 207 183 1499
New Road
https://www.poolbegpharma.com/
Jeremy Skillington, CEO of Poolbeg Pharma and Cathal Friel tell us about the recently signed option agreement with University College Dublin for a Melioidosis Vaccine candidate, MelioVac, and a licence to evaluate 5 other infectious disease portfolio assets.
